So what happen was FDA did not give approval.
A type A meeting was then requested which looks like happening on second and third quarter of the year
But before that MSB have issues with their financials.
Then suddenly, out of the left field, a US base strategic investor with network of doctors save the day like Avengers by injecting fresh fund to the company.
The purpose of the fund is for clinical testing, working capital and for manufacturing and distribution of the product candidates.
What a roller coster ride of lucky coincidences.
Looks like the Big boys are playing so I have to just go in the corner and watch them play as I hold on.
MSB to dispute FDA finding in Type A meeting, page-984
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |